These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. The effect of aminophylline on cerebral blood flow in patients with chronic obstructive pulmonary disease. Bowton DL; Alford PT; McLees BD; Prough DS; Stump DA Chest; 1987 Jun; 91(6):874-7. PubMed ID: 3581935 [TBL] [Abstract][Full Text] [Related]
45. Preliminary study of the effects of postoperative methylprednisolone therapy on lung function recovery in patients with chronic obstructive pulmonary disease. Fraser IM; Hyland RH; Hutcheon MA; MacKenzie RL; Ameli FM; Provan JL Clin Pharm; 1989 Mar; 8(3):214-9. PubMed ID: 2706894 [No Abstract] [Full Text] [Related]
46. The design of oral sustained-release theophylline dosing after conversion from intravenous to oral therapy. Yamazaki M; Fukutomi O; Kondo N; Kato Z; Nakashima Y; Shinoda S; Agata H; Kondo T; Imaeda N; Orii T Int J Clin Pharmacol Ther; 1994 Nov; 32(11):625-31. PubMed ID: 7874380 [TBL] [Abstract][Full Text] [Related]
47. [Hemodynamic and therapeutic significance of plasma atrial natriuretic peptide in chronic lung diseases]. Hiraga T Hokkaido Igaku Zasshi; 1991 Mar; 66(2):201-14. PubMed ID: 1829435 [TBL] [Abstract][Full Text] [Related]
48. [Clinical significance of the determination of serum aminophylline levels]. Xia XR; Kang XM; Tang ZQ Zhonghua Nei Ke Za Zhi; 1985 Jul; 24(7):406-8, 446. PubMed ID: 4053802 [No Abstract] [Full Text] [Related]
49. Effects of drugs on aminophylline elimination in rats. Szeitz A; Herjavecz I; Debreczeni LA Arzneimittelforschung; 1988 Dec; 38(12):1811-4. PubMed ID: 3266736 [TBL] [Abstract][Full Text] [Related]
50. Controversies in pulmonary medicine. Aminophylline should be administered for all acute exacerbations of COPD. Ziment I; Niewoehner DE Am Rev Respir Dis; 1988 Oct; 138(4):1070. PubMed ID: 3202440 [No Abstract] [Full Text] [Related]
51. [Possibilities for optimizing therapy with theophylline preparations. I. On the pharmacokinetics of theophylline preparations]. Wiesner B; Sehrt I; Iwainsky H Z Erkr Atmungsorgane; 1984; 162(1):3-10. PubMed ID: 6719957 [TBL] [Abstract][Full Text] [Related]
52. Theophylline-induced alterations in cardiac electrophysiology in patients with chronic obstructive pulmonary disease. Eiriksson CE; Writer SL; Vestal RE Am Rev Respir Dis; 1987 Feb; 135(2):322-6. PubMed ID: 3813192 [TBL] [Abstract][Full Text] [Related]
53. [Relation of dose, serum concentration and side effects in intravenous aminophylline therapy]. Katz G; Kewitz G; Vozeh S; Follath F Schweiz Med Wochenschr; 1981 Dec; 111(52):2054-6. PubMed ID: 7330656 [TBL] [Abstract][Full Text] [Related]
54. Erythromycin and common cold in COPD. Suzuki T; Yanai M; Yamaya M; Satoh-Nakagawa T; Sekizawa K; Ishida S; Sasaki H Chest; 2001 Sep; 120(3):730-3. PubMed ID: 11555501 [TBL] [Abstract][Full Text] [Related]
57. [Clinical and physiological features of chronic pulmonary emphysema with paroxysmal dyspnea attacks masquerading as bronchial asthma--improvement of respiratory function after combination therapy of intravenous aminophylline and subcutaneous epinephrine following daily oral administration of prednisolone]. Toda M; Motojima S; Fukuda T; Makino S Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Apr; 29(4):460-8. PubMed ID: 1865598 [TBL] [Abstract][Full Text] [Related]
58. The effect of aminophylline on cardiac rhythm in advanced chronic obstructive pulmonary disease: correlation with serum theophylline levels. Dutt AK; de Soyza ND; Au WY; Hargis JL; Tuck RL Eur J Respir Dis; 1983 May; 64(4):264-70. PubMed ID: 6861921 [TBL] [Abstract][Full Text] [Related]
59. The use of theophylline clearance to design an oral aminophylline regimen. Simmons SM; Camp RB; Mungall DR; Bailey WC Ala J Med Sci; 1982 Apr; 19(2):142-6. PubMed ID: 7102998 [No Abstract] [Full Text] [Related]